PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×
Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
— 0.00 0.00 3.99 5.72
P/S ratio
— 7.04 2.13 1.39 1.50
P/FCF ratio
— 5.49 5.80 3.04 3.18
P/Operating CF
— (20.14) (204.47) (25.57) 23.34
P/B ratio
— 0.65 0.58 0.53 0.48
EV/Sales
— 4.45 0.77 0.10 1.46
EV/EBITDA
— 0.00 0.00 0.13 2.35
EV/FCF
— 3.47 2.09 0.21 3.10
Current Ratio
— 6.87 9.86 3.32 3.05
Net Debt/EBITDA
— 2.02 11.51 (1.79) (0.06)
Debt/Equity
— 0.05 0.17 0.14 0.31
ROE
— (10.64%) (8.74%) 13.83% 8.76%
ROA
0.00% (8.38%) (6.24%) 9.01% 5.71%
ROIC
— (14.61%) (6.88%) 28.09% 10.85%
Return on Tangible Assets
— (25.72%) (14.58%) 24.36% 23.76%
Average Days of Receivables
— 90.34 39.88 35.56 59.94
Earnings Yield
— (19.38%) (15.52%) 25.09% 17.49%
Free Cash Flow Yield
— 18.23% 17.25% 32.87% 31.42%
Free Cash Flow per Share
— 0.42 0.27 0.94 0.70
Book value per Share
— 5.00 5.01 5.44 4.61
Free Cash Flow
— 49.37 40.02 146.58 114.78
EV/EBIT
— 0.00 0.00 0.16 2.75
Other line items

Show all line items

Columns are period end dates